User profiles for "author:Takafumi Suda"

Takafumi Suda

Hamamatsu University School of Medicine, Respiratory Medicine
Verified email at hama-med.ac.jp
Cited by 20747

The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype

AL Olson, AH Gifford, N Inase… - European Respiratory …, 2018 - Eur Respiratory Soc
The availability of epidemiological data relating to interstitial lung diseases (ILDs) has
increased over recent years, but information on the prevalence and incidence of ILDs of …

Eosinophilic pneumonia: a review of the previous literature, causes, diagnosis, and management

Y Suzuki, T Suda - Allergology International, 2019 - jstage.jst.go.jp
abstract Eosinophilic pneumonia (EP) is a rare disorder, comprising several heterogeneous
diseases. Two major types of EP are acute eosinophilic pneumonia (AEP) and chronic …

2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease

Y Kondoh, S Makino, T Ogura, T Suda, H Tomioka… - Respiratory …, 2021 - Elsevier
The prognosis of patients with connective tissue disease (CTD) has improved significantly in
recent years, but interstitial lung disease (ILD) associated with connective tissue disease …

Cumulative incidence of and predictive factors for lung cancer in IPF

Y Ozawa, T Suda, T Naito, N Enomoto… - …, 2009 - Wiley Online Library
Background and objective: Previous studies have indicated a high incidence of lung cancer
in IPF, and some have identified its risk factors. However, those studies were retrospective …

Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer

Y Suzuki, T Suda, K Furuhashi, M Suzuki, M Fujie… - Lung cancer, 2010 - Elsevier
BACKGROUND: Indoleamine 2, 3-dioxygenase (IDO) catalyzes the rate-limiting step of
tryptophan (Trp) degradation along the kynurenine (Kyn) pathway. By depleting tryptophan …

[HTML][HTML] Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases

T Suda, Y Kaida, Y Nakamura, N Enomoto… - Respiratory …, 2009 - Elsevier
BACKGROUND: Acute exacerbation (AE) is currently established as a distinct condition with
acute deterioration of respiratory status in idiopathic pulmonary fibrosis (IPF). Recently …

Higher Sensitivity and Specificity for Diffusion-weighted Imaging of Malignant Lung Lesions without Apparent Diffusion Coefficient Quantification1

T Uto, Y Takehara, Y Nakamura, T Naito, D Hashimoto… - Radiology, 2009 - pubs.rsna.org
Purpose: To compare the performance of apparent diffusion coefficient (ADC) with that of
signal intensity of the lesion-to–spinal cord ratio (LSR) in differentiating lung cancer from …

Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis.

T Fujisawa, T Suda, Y Nakamura, N Enomoto… - The Journal of …, 2005 - jrheum.org
OBJECTIVE: To assess the difference in clinical features and prognosis of patients with
interstitial lung disease (ILD) comparing polymyositis (PM) and dermatomyositis (DM) …

Antiinflammatory roles of peroxisome proliferator–activated receptor γ in human alveolar macrophages

K Asada, S Sasaki, T Suda, K Chida… - American journal of …, 2004 - atsjournals.org
Peroxisome proliferator–activated receptor γ (PPARγ) is a ligand-activated transcriptional
factor belonging to the nuclear receptor superfamily. PPARγ, which is predominantly …

[HTML][HTML] Prognostic factors for myositis-associated interstitial lung disease

T Fujisawa, H Hozumi, M Kono, N Enomoto… - PLoS one, 2014 - journals.plos.org
Background Interstitial lung disease (ILD) is a common manifestation of polymyositis (PM),
dermatomyositis (DM), and clinically amyopathic dermatomyositis (CADM); however, little is …